Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT00345410
Show Display Options
Rank Status Study
1 Completed Dose-Ranging Study Evaluating AVE1625 in Abdominally Obese Patients With Atherogenic Dyslipidemia
Conditions: Obesity;   Dyslipidemia
Intervention: Drug: AVE1625 B

Indicates status has not been verified in more than two years